Interferon treatment of chronic active h
✍
Waldron, Peter
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 42 KB
👁 2 views
Due to concerns that antineoplastic therapy produces prolonged decrease in immune function, interferon treatment of chronic active hepatitis C (CAHC) has been used only at one year or longer after the end of cancer therapy. We report the experience of an 11-year-old who developed symptomatic CAHC at